Genetec Technology Bhd co-founder Aaron Chen Khai Voon has emerged as a substantial shareholder in Sunzen Group Bhd, according to a Bursa Malaysia filing.
Chen acquired 32.7 million Sunzen shares, representing a 4.3% stake, through a direct business deal on March 4. Following the purchase, he now holds 8.51% of Sunzen, making him the company’s second-largest shareholder behind group managing director Teo Yek Ming, who holds 14.685%.
The filing did not disclose the purchase price, but based on Sunzen’s volume-weighted average price (VWAP) of 25.5 sen, the transaction is estimated at RM8.34 million.
Sunzen has shifted its focus from traditional animal health products to human health products and loan financing services. The company has been profitable since FY2021, though earnings have remained modest.
For the first half of FY2026 (ended Dec 31, 2025), Sunzen reported a net profit of RM7.54 million, up sharply from RM2.42 million a year earlier, while revenue stayed relatively stable at RM49.92 million. Growth was driven by the human health division, which returned to profit, and a 63% increase in loan financing earnings, supported by higher interest income and improved bad debt recovery.
Chen, who exited as a substantial shareholder in Genetec in May 2025, currently holds major stakes in other companies, including Seal Incorporated Bhd (28.65%), TSA Group Bhd (41.18%), and 10% of ACE Market newcomer PEOPLElogy Bhd.
Sunzen shares closed unchanged at 25 sen on Thursday, giving the company a market value of RM205.45 million, while the stock has fallen 16.7% over the past year.
